COMPANY
Myriad Genetics
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Business Data Engineer | Salt Lake City, UT, United States | Oct 21, 2026 | Oct 22, 2026 |
| Sales Executive - Mental Health/Hereditary Cancer Risk Testing - Indianapolis, IN | Indianapolis, IN, United States | Oct 16, 2026 | Oct 17, 2026 |
| Lab Technologist II - MRD | Salt Lake City, UT, United States | Oct 15, 2026 | Oct 16, 2026 |
| Forecasting and Analytics Sr Director | United States | Oct 15, 2026 | Oct 16, 2026 |
| Sales Executive - Prenatal - Charleston, SC | Charleston, SC, United States | Oct 14, 2026 | Oct 16, 2026 |
Timeline
- Debt Debt: $200M (not counted as a raise), announced Jul 31, 2025. Source: SEC filing. source ↗
Funding
- Debt: $200M (not counted as a raise), announced Jul 31, 2025. Source: SEC filing. source ↗
NIH awards 2
- NIH contract (government contract; not a grant and not an investment round) N01AI40057-9-0-1 FY2009: $153,056 awarded for that fiscal year; activity N01 (OTHER_NIH); PI LANCHBURY, JERRY; recipient as written: MYRIAD GENETICS, INC., SALT LAKE CITY, UT. IDENTIFY source ↗
- NIH award 1R43CA086644-01 FY2000: $185,130 awarded for that fiscal year; activity R43 (SBIR); PI MORHAM, SCOTT G; recipient as written: MYRIAD GENETICS, INC., SALT LAKE CITY, UT. IDENTIFICATION OF COLON CANCER PREDIS source ↗
Raises and investors new
- InvestorListed in the portfolio of OrbiMed (captured Oct 12, 2026). portfolio page ↗
Open jobs 15
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Business Data Engineer | Salt Lake City, UT, United States | Oct 21, 2026 | Oct 22, 2026 | Not stated |
| Sales Executive - Mental Health/Hereditary Cancer Risk Testing - Indianapolis, IN | Indianapolis, IN, United States | Oct 16, 2026 | Oct 17, 2026 | Not stated |
| Lab Technologist II - MRD | Salt Lake City, UT, United States | Oct 15, 2026 | Oct 16, 2026 | Not stated |
| Forecasting and Analytics Sr Director | United States | Oct 15, 2026 | Oct 16, 2026 | Not stated |
| Sales Executive - Prenatal - Charleston, SC | Charleston, SC, United States | Oct 14, 2026 | Oct 16, 2026 | Not stated |
| Histopathology Associate I (Histotech in Training) | Salt Lake City, UT, United States | Oct 13, 2026 | Oct 16, 2026 | Not stated |
| Part Time Specimen Processor I | Mason, OH, United States | Oct 13, 2026 | Oct 16, 2026 | Not stated |
| Sales Executive - Urology - Georgia | Atlanta, GA, United States | Oct 7, 2026 | Oct 16, 2026 | Not stated |
| Sales Executive - Prenatal - Boston South | Boston, MA, United States | Oct 5, 2026 | Oct 16, 2026 | Not stated |
| Sales Executive - Urology - St. Louis, MO | St Louis, MO, United States | Sep 29, 2026 | Oct 16, 2026 | Not stated |
| Key Account Manager - North Texas | Dallas, TX, United States | Sep 24, 2026 | Oct 16, 2026 | Not stated |
| Sales Executive - Mental Health/Hereditary Cancer Risk Testing - Milwaukee, WI | Milwaukee, WI, United States | Sep 24, 2026 | Oct 16, 2026 | Not stated |
| Sales Executive - Hereditary Cancer Screening - Queens, NY | Queens, NY, United States | Sep 14, 2026 | Oct 16, 2026 | Not stated |
| Lead Product Manager Customer Experience - EPIC EMR Integrations | Salt Lake City, UT, United States | Sep 1, 2026 | Oct 16, 2026 | Not stated |
| Sales Executive - Mental Health/Hereditary Cancer Risk Testing - Traverse City, MI | Traverse City, MI, United States | Aug 25, 2026 | Oct 16, 2026 | Not stated |
Connect
See your connections at Myriad Genetics on LinkedIn (search by name, results not checked)